看见一个 Expert Review of Anticancer Therapy。你们前面用依维莫斯,血、肝肾功能还好。下一步是否考虑索拉非尼+依维莫斯。供你参考。
5 [5 {# b3 O4 @1 C" q8 |% H2 v$ U; l
8 V( f: E# T' L" k, }7 Z$ sCurrently available feasibility data for possible combination strategies.
; t% [7 I& K6 {9 T————————————————————————————————( B4 q/ J5 R8 z* |5 u' G3 T2 I
Combination Feasibility according to preliminary data 5 l3 m. y' M8 C; `/ W
——————————————————————————————————
9 \& m6 o, H! y& d {0 n& LBevacizumab + sorafenib Yes, reduced dose
3 i5 w1 n& W2 g! f2 I. P% sBevacizumab + sunitinib† No
# E2 }) J5 z' T: SBevacizumab + temsirolimus Yes 2 I! F$ b; c7 \/ u4 ~& K- H
Bevacizumab + everolimus Yes 7 u# `" I$ p% S L7 [
Sorafenib + sunitinib ?
8 T8 N8 y" v3 {! W9 [# i$ ^( Q7 ESorafenib + temsirolimus Yes, reduced dose
* r" D* T) N2 f" S3 f+ Z6 zSorafenib + everolimus Yes, reduced dose . r6 J; O! C2 {2 e% Y
Sunitinib + temsirolimus† No
2 j) T+ @+ ~- \3 DSunitinib + everolimus ?
0 {- H7 t4 O) z% e. wTemsirolimus + everolimus ?
2 x* `4 { V f; F7 s+ Y8 L# T————————————————————0 g4 c* l) i6 z, W. I) [ C
†Led to US FDA warning.
' {8 v; V" C' `% J: ]: T?: As yet unattempted combination.
' r- z( ^( L& [7 V6 Y% t |